Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 3
Submit an article Journal homepage
4,767
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Teneligliptin: expectations for its pleiotropic action

Ryuichi MorishitaOsaka University, School of Medicine, Department of Clinical Gene Therapy, 2-2 Yamada-oka, Suita 565-0871, Osaka, Japan+81 6 6879 3406; +81 6 6879 3409; [email protected]
, MD PhD (Professor) &
Hironori NakagamiOsaka University, School of Medicine, Department of Clinical Gene Therapy, 2-2 Yamada-oka, Suita 565-0871, Osaka, Japan+81 6 6879 3406; +81 6 6879 3409; [email protected]
, MD PhD (Professor)
Pages 417-426 | Published online: 19 Jan 2015

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Baptist Gallwitz. (2017) A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes. Expert Opinion on Drug Safety 16:12, pages 1399-1405.
Read now
Yoshinori Okuda, Seitaro Omoto, Takehito Taniura, Akira Shouzu & Shosaku Nomura. (2016) Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis. International Journal of General Medicine 9, pages 65-71.
Read now
Surendra Kumar Sharma, A Panneerselvam, KP Singh, Girish Parmar, Pradeep Gadge & Onkar C Swami. (2016) Teneligliptin in management of type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity 9, pages 251-260.
Read now
Baptist Gallwitz. (2015) Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin. Therapeutics and Clinical Risk Management 11, pages 799-805.
Read now
Takashi Kadowaki, Fuyuhiko Marubayashi, Shoko Yokota, Makoto Katoh & Hiroaki Iijima. (2015) Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies. Expert Opinion on Pharmacotherapy 16:7, pages 971-981.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.